KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Inventory Average (2016 - 2025)

Historic Inventory Average for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $3.3 billion.

  • Teva Pharmaceutical Industries' Inventory Average fell 666.09% to $3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 666.09%. This contributed to the annual value of $3.1 billion for FY2025, which is 11629.37% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Inventory Average stood at $3.3 billion for Q4 2025, which was down 666.09% from $3.4 billion recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Inventory Average peaked at $4.4 billion during Q1 2021, and registered a low of $1.9 billion during Q1 2024.
  • Moreover, its 5-year median value for Inventory Average was $3.9 billion (2024), whereas its average is $3.7 billion.
  • Over the last 5 years, Teva Pharmaceutical Industries' Inventory Average had its largest YoY gain of 7843.24% in 2024, and its largest YoY loss of 5218.21% in 2024.
  • Teva Pharmaceutical Industries' Inventory Average (Quarter) stood at $4.0 billion in 2021, then decreased by 3.67% to $3.8 billion in 2022, then crashed by 49.25% to $2.0 billion in 2023, then skyrocketed by 78.43% to $3.5 billion in 2024, then dropped by 6.66% to $3.3 billion in 2025.
  • Its Inventory Average was $3.3 billion in Q4 2025, compared to $3.4 billion in Q3 2025 and $3.4 billion in Q2 2025.